Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Pogue-Geile, Michael F.
and
Zubin, Joseph
1987.
Negative Symptomatology and Schizophrenia: A Conceptual and Empirical Review.
International Journal of Mental Health,
Vol. 16,
Issue. 4,
p.
3.
Singh, Man Mohan
and
Kay, Stanley R.
1987.
Is the Positive-Negative Distinction in Schizophrenia Valid?.
British Journal of Psychiatry,
Vol. 150,
Issue. 6,
p.
879.
GARDNER, ELIOT L.
and
SEEGER, THOMAS F.
1988.
Anatomically Selective Action of Atypical Neuroleptics on the Mesocorticolimbic Dopamine System.
Annals of the New York Academy of Sciences,
Vol. 537,
Issue. 1,
p.
502.
Kay, Stanley R.
Opler, Lewis A.
and
Lindenmayer, Jean-Pierre
1988.
Reliability and validity of the positive and negative syndrome scale for schizophrenics.
Psychiatry Research,
Vol. 23,
Issue. 1,
p.
99.
Ellenbroek, B.
and
Cools, A.R.
1988.
The PAW test: An animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism.
Life Sciences,
Vol. 42,
Issue. 12,
p.
1205.
Kay, Stanley R.
Opler, Lewis A.
and
Lindenmayer, Jean-Pierre
1989.
The Positive and Negative Syndrome Scale (PANSS): Rationale and Standardisation.
British Journal of Psychiatry,
Vol. 155,
Issue. S7,
p.
59.
Tandon, Rajiv
Mann, Nancy A.
Eisner, William H.
and
Coppard, Nancy
1990.
Effect of anticholinergic medication on positive and negative symptoms in medication-free schizophrenic patients.
Psychiatry Research,
Vol. 31,
Issue. 3,
p.
235.
Sandyk, Reuven
and
Kay, Stanley R.
1990.
The Relationship of Negative Schizophrenia to Parkinsonism.
International Journal of Neuroscience,
Vol. 55,
Issue. 1,
p.
1.
Sandyk, Reuven
and
Kay, Stanley R.
1991.
The relationship of tardive dyskinesia to positive Schizophrenia.
International Journal of Neuroscience,
Vol. 56,
Issue. 1-4,
p.
107.
Deutch, Ariel Y.
Moghaddam, Bita
Innis, Robert B.
Krystal, John H.
Aghajanian, George K.
Bunney, Benjamin S.
and
Charney, Dennis S.
1991.
Mechanisms of action of atypical antipsychotic drugs.
Schizophrenia Research,
Vol. 4,
Issue. 2,
p.
121.
Tandon, Rajiv
Shipley, James E.
Greden, John F.
Mann, Nancy A.
Eisner, William H.
and
Goodson, JoAnn
1991.
Muscarinic cholinergic hyperactivity in schizophrenia.
Schizophrenia Research,
Vol. 4,
Issue. 1,
p.
23.
Qureshi, Naseem A.
1992.
Trihexyphenidyl (Artane) Abuse among Saudi Psychiatric Patients.
Annals of Saudi Medicine,
Vol. 12,
Issue. 4,
p.
391.
Horiguchi, Jun
and
Nishimatsu, Ohichi
1992.
Usefulness of Antiparkinsonian Drugs during Neuroleptic Treatment and the Effect of Clonazepam on Akathisia and Parkinsonism Occurred after Antiparkinsonian Drug Withdrawal: A Double‐Blind Study.
Psychiatry and Clinical Neurosciences,
Vol. 46,
Issue. 3,
p.
733.
Kawasaki, Yasuhiro
Suzuki, Michio
Maeda, Yoshiki
Urata, Katsumi
Yamaguchi, Nariyoshi
Matsuda, Hiroshi
Hisada, Kinichi
Suzuki, Masayuki
and
Takashima, Tsutomu
1992.
Regional cerebral blood flow in patients with schizophrenia.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 241,
Issue. 4,
p.
195.
Fritze, J.
1992.
Neuro-Psychopharmaka Ein Therapie-Handbuch.
p.
59.
Callaway, Enoch
Halliday, Roy
and
Naylor, Hilary
1992.
Cholinergic activity and constraints on information processing.
Biological Psychology,
Vol. 33,
Issue. 1,
p.
1.
Ellenbroek, B.A.
1993.
Treatment of schizophrenia: A clinical and preclinical evaluation of neuroleptic drugs.
Pharmacology & Therapeutics,
Vol. 57,
Issue. 1,
p.
1.
Tandon, Rajiv
Greden, John F.
and
Haskett, Roger F.
1993.
Cholinergic hyperactivity and negative symptoms: behavioral effects of physostigmine in normal controls.
Schizophrenia Research,
Vol. 9,
Issue. 1,
p.
19.
Gaebel, W.
1993.
Therapie im Grenzgebiet von Psychiatrie und Neurologie.
p.
54.
Miller, Robert
1997.
Dose-response relationships for the antipsychotic effects and Parkinsonian side-effects of typical neuroleptic drugs: Practical and theoretical implications.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 21,
Issue. 7,
p.
1059.